This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aventis Pharma S.a.. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Paris, FR (2013)
- Brunoy, FR (2018)
Company Filing History:
Years Active: 2013-2018
Title: Marielle Dufraigne: Innovator in Pharmaceutical Chemistry
Introduction
Marielle Dufraigne is a prominent inventor based in Brunoy, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of 2 patents, her work has garnered attention in the scientific community.
Latest Patents
Dufraigne's latest patents focus on the crystalline forms of dimethoxy docetaxel and methods for preparing these compounds. The inventions relate to anhydrides, solvates, and ethanol hetero-solvates and hydrates of dimethoxy docetaxel. This includes the compound (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxo-tax-11-ene-13α-yl, along with the preparation methods for these forms.
Career Highlights
Marielle Dufraigne is currently employed at Aventis Pharma S.A., where she continues to push the boundaries of pharmaceutical research. Her work has been instrumental in advancing the understanding and application of complex chemical compounds in medicine.
Collaborations
Throughout her career, Dufraigne has collaborated with notable colleagues, including Pascal Billot and Hagit Elmaleh. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Marielle Dufraigne stands out as a key figure in pharmaceutical innovation, with her patents reflecting her expertise and dedication to advancing medical science. Her contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
